Thought Leadership | Fish & Richardson

Diversity, Equity & Inclusion

Pro Bono & Social Responsibility

Legal Operations

Legal Project Management

Knowledge Management

Legal Technology Services

Patent Litigation

Trademark, Copyright & Media Litigation

Trade Secret Litigation

Standard Essential Patents

Chancery & Corporate Governance

<p><em>Inter Partes </em>Review</p>

Post-Grant Review

<p><em>Ex Parte</em> Reexamination</p>

Supplemental Examination

Patent Prosecution

Strategic Patent Counseling & Opinions

Patent Portfolio Management

Unitary Patent & Unified Patent Court

IP Licensing, Transactions & Agreements

Trademark & Copyright Counseling & Prosecution

Strategic Counseling, Registration & Opinions

Advertising & Marketing

Domain Names & Internet

TTAB Oppositions & Cancellations

Digital Millennium Copyright Act

Transactions & Agreements

Regulatory & Government Affairs

Communications & Spectrum Regulation

Drug & Medical Device Regulation

mHealth & Telemedicine

Privacy & Data Security

Electrical & Computer Technology

Software & Internet

Consumer Electronics

Artificial Intelligence

Digital Media & E-Commerce

Financial, Business & FinTech Services

Telecommunications

Energy & Chemicals

Biotech & Diagnostics

Medical Devices

Pharmaceuticals

Academic Research & Medical Centers

Transportation, Aerospace & Defense

Autonomous Vehicles

Thought Leadership

IP Law Essentials

Post-Grant Annual Reports

Blog | August 01, 2016

Final FDA Guidance on "Low Risk Wellness" Products Adopts Novel Approach for Exempting Devices From Regulation

Blog | July 27, 2016

Federal Circuit Explains Burden Shifting in IPRs

Blog | July 25, 2016

Can Reference Product Sponsor Forfeit Right To Sue Under BPCIA?

Blog | July 20, 2016

Half-baked Specimens Doom HERBAL ACCESS Application at TTAB

Blog | July 18, 2016

Southern District of Florida Finds Defendant Failed to Meet its Burden With Laches Defense

Blog | July 13, 2016

Post-Prosecution Pilot ("P3") Program

Blog | June 30, 2016

Remedy to Incentivize Innovation as In Vitro Diagnostics Face Patent-Eligibility Challenges and Added Regulatory Scrutiny

Article | June 30, 2016

Biologic Patents Are Under Attack

Blog | June 27, 2016

IP Rights & Brexit

Blog | June 24, 2016

Impact of Brexit Vote on Design Protection in the EU

Blog | June 24, 2016

Patent Litigation for the Non-Specialist: How it Works and What to Expect

Blog | June 23, 2016

USPTO Seeking Comment on Proposed Rulemaking for Trademark Registration Maintenance